Capital Fund Management S.A. Lowers Stock Position in HCA Healthcare, Inc. $HCA

Capital Fund Management S.A. decreased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 35.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 57,983 shares of the company’s stock after selling 31,878 shares during the period. Capital Fund Management S.A.’s holdings in HCA Healthcare were worth $22,213,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of HCA. ORG Partners LLC increased its stake in shares of HCA Healthcare by 27.9% in the second quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after buying an additional 31 shares during the period. Glenview Trust co raised its holdings in HCA Healthcare by 2.3% in the first quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after purchasing an additional 32 shares in the last quarter. Horizon Investments LLC increased its stake in shares of HCA Healthcare by 1.1% during the first quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock valued at $1,097,000 after purchasing an additional 33 shares in the last quarter. Sivia Capital Partners LLC boosted its position in shares of HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares in the last quarter. Finally, RWA Wealth Partners LLC increased its position in HCA Healthcare by 2.0% during the 1st quarter. RWA Wealth Partners LLC now owns 1,904 shares of the company’s stock valued at $658,000 after buying an additional 37 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Down 0.4%

Shares of NYSE HCA opened at $512.94 on Friday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $520.00. The firm has a market capitalization of $117.05 billion, a price-to-earnings ratio of 19.83, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. The firm has a 50 day moving average of $452.07 and a 200 day moving average of $406.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio is currently 11.13%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on HCA shares. Oppenheimer raised their price target on HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a report on Monday, October 27th. Wall Street Zen upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 25th. Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a report on Monday. Jefferies Financial Group lifted their target price on HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a report on Tuesday, October 28th. Finally, Mizuho increased their price objective on HCA Healthcare from $475.00 to $505.00 and gave the company an “outperform” rating in a research report on Monday, October 27th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $474.53.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.